Products

PCR.AI
diagnostics.ai
Lab & Diagnostics
PCR.AI is an AI-powered platform that automates the analysis, quality control, and reporting of real-time PCR data, using machine learning algorithms to interpret fluorescence curves and classify results.

See all 1 product →

About diagnostics.ai

diagnostics.ai, formerly known as Azure PCR, is a UK-based healthcare AI company founded in 2009. Their core mission is to address patient safety issues stemming from problems in diagnostic testing by leveraging data science, artificial intelligence, and machine learning. The company develops automated PCR data analysis software, with their flagship product being pcr.ai. This platform automates data analysis in molecular diagnostics and research, aiming to provide instant diagnoses from blood or urine samples.

For physicians, diagnostics.ai’s technology offers several key benefits. The pcr.ai platform automates the widely-used qPCR method for infection testing, significantly reducing human error and improving reliability in laboratory operations. The AI Analysis Engine component of pcr.ai is CE-IVDR & MHRA registered as a Class A medical device software and has demonstrated over 99.9% interpretation accuracy in clinical validation studies. This enhanced accuracy and automation can lead to more precise patient treatment plans, improved patient safety, and reduced costs. The system also supports integration with laboratory information systems (LIMS/LIS) through various methods, including HL7, FHIR, REST APIs, and direct database connections, facilitating seamless workflow integration in clinical settings.

Focus Areas

AI-based automated diagnostics PCR data analysis machine learning in molecular diagnostics infection detection quality control in diagnostics laboratory automation

Business Intelligence

Key InvestorsAI Venture Labs
PartnershipsViapath (implementing diagnostics.ai for molecular diagnostics automation)
TechnologyAI-based learning machines, cloud-native (SOC 2 certified infrastructure), CE-IVDR certified AI Analysis Engine, API for integration with existing solutions

What Physicians Need to Know

AI-based Automated Diagnostics
diagnostics.ai specializes in AI-powered platforms that automate the analysis, quality control, and reporting of real-time PCR data. Their AI Analysis Engine has demonstrated >99.9% interpretation accuracy in clinical validation studies. This technology analyzes hundreds of data points per curve, identifying complex patterns and curve shapes, which significantly reduces false positives and handles high-noise environments, eliminating the need for manual configuration.
PCR Data Analysis
The company's PCR.AI platform uses advanced machine learning algorithms to interpret fluorescence curves, automatically classify results, apply quality control checks, and generate standardized reports. This approach is superior to traditional methods that rely on simple threshold crossing points, which are limited and error-prone. PCR.AI supports all major real-time PCR instruments, including Applied Biosystems, Bio-Rad, Qiagen, and Roche systems.
Machine Learning in Molecular Diagnostics
diagnostics.ai leverages machine learning to achieve unparalleled accuracy, availability, and automation in diagnostic laboratories. Their clinically-proven and certified technologies ensure high-quality results for routine testing. This includes advanced rules engines and QC, such as Westgard rules, for comprehensive analysis.
Infection Detection
By automating PCR data analysis and quality control, diagnostics.ai contributes to faster and more accurate infection detection. The system's ability to quickly and reliably interpret PCR results can significantly reduce turnaround times and improve the efficiency of infectious disease diagnostics.
Quality Control in Diagnostics
PCR.AI provides automated quality controls, complete audit trails, and standardized reporting, which are crucial for laboratory accreditation (e.g., ISO 15189, CAP, and CLIA requirements). The system automatically identifies and evaluates all standard control types, including positive, negative, extraction, and internal controls, applying appropriate quality checks and flagging failures based on laboratory-defined rules.
Laboratory Automation
diagnostics.ai offers solutions like the Integrated Workbench for end-to-end analysis and Device Manager to standardize tests and connect various sample-to-answer platforms. These tools streamline workflows, reduce hands-on time, and make data more accessible, ultimately leading to quicker results with lower costs and less risk of errors.
Physician Tip

For physicians, diagnostics.ai offers a significant advantage by providing highly accurate and automated diagnostic insights, particularly for PCR testing. The AI-powered analysis reduces the risk of human error and false positives, leading to more reliable results and supporting faster, more informed clinical decision-making. This allows physicians to focus more on patient care and complex cases, as routine analysis and data review are automated. The system's ability to integrate with existing LIMS/LIS systems ensures seamless data flow and comprehensive diagnostic insights, contributing to earlier disease detection and improved patient outcomes. While AI assists in diagnosis, it's important to remember it serves as a supportive 'second opinion' tool, augmenting clinical judgment rather than replacing it.

diagnostics.ai's PCR.AI platform is designed for flexible integration with laboratory information systems (LIMS/LIS) through various methods. The Enterprise Edition offers bidirectional integration capabilities supporting HL7, FHIR, REST APIs, and direct database connections. This ensures compatibility with existing laboratory infrastructure and facilitates a fully automated resulting process.

Products by diagnostics.ai

1 product in the directory

PCR.AI
diagnostics.ai
Lab & Diagnostics
PCR.AI is an AI-powered platform that automates the analysis, quality control, and reporting of real-time PCR data, using machine learning algorithms to interpret fluorescence curves and classify results.

What the Web Says

diagnostics.ai, particularly with its PCR.AI product, receives overwhelmingly positive feedback from healthcare professionals. The platform is praised for its high accuracy in PCR analysis, time-saving capabilities, and reduction of errors in diagnostic workflows. It is viewed as a valuable tool that enhances clinical diagnostic services and improves overall quality in laboratories.

Overall: Positive

Strengths

  • Highly accurate in PCR analysis (>99.9% interpretation accuracy).
  • Time-saving and reduces complexity of qPCR analysis.
  • Reduces analysis issues due to operator error and flags erroneous results.
  • Easy-to-use interface with minimal training required.
  • Improves clinical diagnostic service and quality.
  • Offers flexible LIMS integration and secure, ISO27001 certified data handling.

Limitations

  • No significant cons were identified in the provided search results regarding diagnostics.ai's products or as an employer.
  • General concerns about AI in healthcare, such as potential for false positives/negatives and the need for human oversight, exist across the industry but are not specific to diagnostics.ai.

Based on reviews from: diagnostics.ai website, G2, Reddit, World Scientific News, Blaze.tech, PMC, MedicalSearch, NIX United, Startup Stash, Capterra

Last updated: 2026-07-07

Videos

News, demos, and interviews about diagnostics.ai.

Loading videos...

Videos load interactively. If none appear, search YouTube for diagnostics.ai →

View all on YouTube

Press & Coverage

Business Wire
Diagnostics.ai Launches Industry's First CE-IVDR Certified Transparent AI Platform for Molecular Diagnostics as Regulatory Deadlines take Effect
Diagnostics.ai has launched the PCR.AI platform, the industry's first fully transparent machine learning platform for clinical real-time PCR diagnostics, achieving CE-IVDR certification as new European regulatory deadlines take effect. The platform demonstrates exactly how each result is achieved, a first for molecular testing machine learning applications.
2025-05
News-Medical.Net
Diagnostics.ai launches fully-transparent machine learning platform for real-time PCR diagnostics
Diagnostics.ai has introduced a fully-transparent machine learning platform for clinical real-time PCR diagnostics, coinciding with the May 26th CE-IVDR compliance deadline. This platform, backed by over 15 years of experience and millions of processed samples with >99.9% accuracy, addresses stringent EU regulations for diagnostic accuracy and transparency.
2025-05
International Hospital
Diagnostics.ai launches first CE-IVDR transparent AI platform
Diagnostics.ai has launched the PCR.AI platform, claiming it to be the industry's first fully transparent machine learning platform for clinical real-time PCR diagnostics, with CE-IVDR certification. This platform offers revolutionary transparency in diagnostic AI, showing precisely how each result is achieved.
2026-06
openPR.com
Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Report 2026 Market Outlook Supported By A Forecast 18.1% CAGR
The AI in in vitro diagnostics market is projected for significant expansion, with Diagnostics.ai's PCR.AI platform highlighted as an innovative solution launched in May 2025. This platform automates and accelerates real-time PCR diagnostics interpretation with over 99.9% accuracy, improving efficiency and regulatory adherence.
2026-07
DeciBio
AI / Machine Learning | June Round-Up 2025
Diagnostics.ai launched the industry's first fully-transparent machine learning platform for clinical real-time PCR diagnostics in response to CE-IVDR regulations. This platform aims to meet heightened standards for diagnostic accuracy, reproducibility, and algorithm transparency.
2025-07
Grand View Research
Artificial Intelligence In Diagnostics Market Report 2026-2033
The global artificial intelligence in diagnostics market is experiencing significant growth, with Diagnostics.ai's May 2025 launch of a CE-IVDR-compliant, fully transparent machine learning platform for real-time PCR diagnostics noted as a key development. This platform aims to make AI decision-making visible, understandable, and traceable.
2026-06
diagnostics.ai
CE-IVDR Compliance for Laboratories | Critical May 2025 Deadline
Diagnostics.ai emphasizes its commitment to regulatory compliance, stating that its PCR.AI API is CE-IVDR certified and MHRA registered, offering a future-proof solution. The company's regulatory team continuously monitors changes to relevant regulations to ensure ongoing compliance.
2025-05
PitchBook
diagnostics.ai 2026 Company Profile: Valuation, Funding & Investors | PitchBook
Diagnostics.ai has raised $2.86 million in funding. The company develops automated PCR data analysis software designed to improve diagnostic accuracy, cut costs, and enhance patient safety through machine learning techniques.
2026

Frequently Asked Questions

Diagnostics.ai leverages internationally patented AI-based learning machines that replicate the decision-making processes of expert clinical technicians. This technology, exemplified by their flagship product pcr.ai, automates routine analyses, eliminates manual steps in patient testing, and boasts an interpretation accuracy exceeding 99.9%, significantly reducing human error and improving reliability in infection detection.
Diagnostics.ai is dedicated to upholding high standards of quality, with its technology undergoing rigorous testing and receiving multiple certifications. Their AI Analysis Engine component within PCR.AI is CE-IVDR & MHRA registered as a Class A medical device software. They provide comprehensive documentation and support for laboratory accreditation (ISO 15189, CAP, CLIA) and continuously monitor evolving regulations.
Diagnostics.ai's primary product is pcr.ai, an AI-powered platform that automates the analysis, quality control, and reporting of real-time PCR data. It supports all major real-time PCR instruments and works with most commercial and laboratory-developed assays. The system offers seamless LIMS integration, automatically exporting analyzed data to existing laboratory information management systems.
While specific pricing details for their Device Manager and Enterprise Edition vary by tier, OEM Partner pricing follows a flexible partnership model. Support options range from standard email support for Device Manager to priority phone support and dedicated Technical Account Managers for Enterprise Edition, with emergency support available across all tiers.
Diagnostics.ai, formerly Azure PCR, was founded in 2009, indicating over a decade of operation in the diagnostic testing space. They emphasize their commitment to quality, with their solutions being used daily by leading clinical labs globally. However, it is important to note that as of April 2026, Diagnostics.ai is an unfunded company.

Related Companies

QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]

Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]

CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]

Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]

OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]

Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.